PDF Cover

Ophthalmic Viscosurgical Devices Market

The market for Ophthalmic Viscosurgical Devices was estimated at $1.1 billion in 2024; it is anticipated to increase to $2.0 billion by 2030, with projections indicating growth to around $3.4 billion by 2035.

Report ID:DS1801420
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Medical Device
Ophthalmic Viscosurgical Devices
Share
Report Summary
Market Data
Methodology
Table of Contents

Global Ophthalmic Viscosurgical Devices Market Outlook

Revenue, 2024

$1.1B

Forecast, 2034

$3.1B

CAGR, 2025 - 2034

11.4%

The Ophthalmic Viscosurgical Devices (OVDs) industry revenue is expected to be around $1.2 billion in 2025 and expected to showcase growth with 11.4% CAGR between 2025 and 2034. The projected expansion underscores the growing strategic importance of Ophthalmic Viscosurgical Devices within modern ophthalmic surgery. Rising global volumes of Cataract Surgery, increasing life expectancy, and broader access to advanced eye-care services are collectively reinforcing demand for these surgical aids. Healthcare providers rely on OVDs to enhance procedural precision, maintain intraocular space, and protect delicate ocular tissues during surgery, making them integral to contemporary ophthalmic workflows. Market momentum is further supported by growing investments in specialized eye hospitals and ambulatory surgical centers, particularly in emerging healthcare markets. Manufacturers are also strengthening their portfolios through product differentiation and surgeon-focused innovations, ensuring that OVDs remain essential in improving surgical outcomes and operational efficiency. As ophthalmology continues to prioritize minimally invasive procedures and higher surgical throughput, OVD adoption remains closely aligned with global efforts to reduce avoidable vision impairment.

Ophthalmic Viscosurgical Devices are specialized viscoelastic formulations designed to maintain anterior chamber stability, protect corneal endothelial cells, and facilitate intraocular manipulation during delicate eye procedures. These devices are primarily used in Cataract Surgery, Glaucoma Surgery, and corneal transplant procedures, where maintaining clear surgical space and minimizing tissue trauma are critical. OVDs typically fall into cohesive, dispersive, or combination formulations, allowing surgeons to select products tailored to procedural requirements. Demand is being shaped by technological advancements in ophthalmic surgical equipment, expanding access to high-volume eye-care programs, and rising awareness of early vision correction procedures. Additionally, ongoing product innovations such as improved viscoelastic formulations that enhance intraoperative control are strengthening their clinical value. The increasing prevalence of age-related ocular disorders and the expansion of ophthalmic surgical capacity worldwide continue to reinforce the role of OVDs in modern eye-care practice.

Ophthalmic Viscosurgical Devices market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2024-2034
Ophthalmic Viscosurgical Devices Market Outlook

Market Key Insights

  • The Ophthalmic Viscosurgical Devices market is projected to grow from $1.1 billion in 2024 to $3.1 billion in 2034. This represents a CAGR of 11.4%, reflecting rising demand across Cataract Surgery, Glaucoma Surgery, and Corneal Transplantation.

  • Alcon Inc., Johnson & Johnson Vision Care Inc., Bausch & Lomb Inc. are among the leading players in this market, shaping its competitive landscape.

  • U.S. and Germany are the top markets within the Ophthalmic Viscosurgical Devices market and are expected to observe the growth CAGR of 8.3% to 12.0% between 2024 and 2030.

  • Emerging markets including Brazil, Indonesia and South Africa are expected to observe highest growth with CAGR ranging between 10.9% to 14.3%.

  • Transition like Transition Toward Premium Viscoelastic Solutions in Advanced Ophthalmic Surgical Procedures is expected to add $222 million to the Ophthalmic Viscosurgical Devices market growth by 2030.

  • The Ophthalmic Viscosurgical Devices market is set to add $2.0 billion between 2024 and 2034, with manufacturer targeting Ambulatory Surgical Centers & Clinics Application projected to gain a larger market share.

  • With

    rising prevalence of ophthalmic disorders, and

    Technological Advancements in OVDs, Ophthalmic Viscosurgical Devices market to expand 194% between 2024 and 2034.

ophthalmic viscosurgical devices market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Ophthalmic Viscosurgical Devices - Country Share Analysis

Opportunities in the Ophthalmic Viscosurgical Devices

Specialized ophthalmic surgery centers in developed healthcare markets are increasingly adopting premium viscoelastic formulations to support complex surgical procedures. Advanced techniques such as micro incision cataract surgery and femtosecond laser assisted operations require precise intraocular control and enhanced tissue protection. This trend is also encouraging demand for viscoadaptive and combination ophthalmic viscosurgical devices that provide both space maintenance and endothelial protection. Private eye hospitals and ambulatory surgical centers are particularly focused on improving surgical precision and patient outcomes, making them key buyers of high performance products. Manufacturers that offer differentiated formulations designed for advanced surgical workflows are expected to benefit most from this opportunity.

Growth Opportunities in North America and Asia-Pacific

The ophthalmic viscosurgical devices market in North America is driven by a highly developed ophthalmology infrastructure and strong adoption of advanced surgical technologies. The region performs a large volume of cataract and glaucoma procedures annually, creating consistent demand for viscoelastic devices used during intraocular surgeries. Growth is supported by the presence of specialized eye hospitals, ambulatory surgery centers, and well-established reimbursement frameworks that encourage the use of high-quality ophthalmic surgical consumables. Opportunities are emerging in premium viscoelastic formulations designed for micro incision cataract surgery and minimally invasive glaucoma procedures. Competition in the region is intense, with leading ophthalmic device companies competing through product innovation, surgeon training programs, and integrated ophthalmic surgery portfolios that combine intraocular lenses, surgical equipment, and viscoelastic devices. Additionally, increasing preference for outpatient surgical settings is driving procurement of efficient and reliable surgical materials. These factors collectively strengthen North America’s position as a technologically advanced and commercially significant market for ophthalmic viscosurgical devices.
Asia Pacific represents one of the fastest expanding markets for ophthalmic viscosurgical devices due to the rising prevalence of cataracts and increasing healthcare accessibility. Countries such as India, China, and Southeast Asian nations are witnessing growing demand for vision correction surgeries as aging populations and urbanization contribute to higher diagnosis rates. Government supported eye care initiatives and large scale cataract elimination programs are creating strong opportunities for cost effective viscoelastic solutions used in high volume surgical settings. Regional competition includes both global ophthalmic device manufacturers and local suppliers offering competitively priced products for public hospitals and community eye clinics. Growth is also supported by expanding private ophthalmology networks and investments in modern surgical facilities. In addition, training programs for ophthalmic surgeons and improved availability of surgical equipment are accelerating procedure adoption. These factors are expected to sustain demand for cohesive and dispersive ophthalmic viscosurgical devices across both public and private healthcare systems in the region.

Market Dynamics and Supply Chain

01

Driver: Rising Global Cataract Surgery Volumes and Expanding Elderly Population Increasing Surgical Demand

A major driver of the ophthalmic viscosurgical devices market is also the steady rise in cataract surgery procedures combined with the rapid expansion of the aging population. Age related eye conditions, particularly cataracts, are also becoming more common as life expectancy increases across many regions. This demographic shift is also directly increasing the number of patients requiring surgical vision correction. Cataract surgery remains the most frequently performed ophthalmic procedure worldwide, and every procedure requires ophthalmic viscosurgical devices to maintain anterior chamber stability and protect sensitive ocular tissues. As governments and healthcare providers expand eye care programs to reduce avoidable blindness, the number of high volume surgical centers is also also increasing. Public health initiatives and mobile surgical camps in developing countries are also improving patient access to treatment, which further expands procedure volumes. This sustained rise in surgical activity continues to generate consistent demand for cohesive and dispersive viscoelastic solutions used during lens removal and intraocular lens implantation.
Advancements in ophthalmic surgical technology are also significantly increasing the reliance on high performance ophthalmic viscosurgical devices. Modern surgical techniques such as micro incision cataract surgery, femtosecond laser assisted procedures, and minimally invasive glaucoma surgery require precise intraocular control and improved protection of delicate eye structures. These sophisticated procedures demand viscoelastic materials that can also maintain a stable operating space while allowing surgeons to manipulate instruments with greater accuracy. As a result, manufacturers are also introducing improved formulations such as viscoadaptive and dual action ophthalmic viscosurgical devices that combine strong tissue protection with efficient space maintenance. These innovations help surgeons perform complex procedures with better visualization and reduced risk of tissue damage. The continuous evolution of ophthalmic surgical equipment and techniques is also therefore strengthening the clinical importance of advanced viscoelastic products, reinforcing their growing role in modern eye surgery practices.
02

Restraint: High Cost of Advanced Viscoelastic Formulations and Limited Reimbursement Coverage in Several Healthcare Systems

One of the primary restraints affecting the ophthalmic viscosurgical devices market is the high cost of advanced viscoelastic formulations combined with inconsistent reimbursement coverage for ophthalmic procedures. Premium OVD formulations often involve specialized materials and extensive clinical validation, which increases production costs and raises the final price for healthcare providers. In many developing and cost-sensitive healthcare systems, hospitals and clinics may opt for lower-priced alternatives or reduce OVD usage to manage budgets, directly affecting product demand and overall market revenue. For example, premium formulations can cost significantly more than conventional viscoelastics, making procurement difficult for smaller eye care facilities and public hospitals. Additionally, delayed or partial reimbursement policies for ophthalmic surgeries in several countries discourage adoption of high-value OVD products, forcing manufacturers to reduce prices or limit market expansion strategies.
03

Opportunity: Expansion of Cataract Surgery Programs Across Emerging Asian Healthcare Systems and Rising Utilization of Viscoelastic Solutions in Minimally Invasive Glaucoma Surgery Procedures

Rapid expansion of cataract treatment programs in emerging Asian healthcare systems presents a significant opportunity for ophthalmic viscosurgical devices. Countries such as India, Indonesia, and Vietnam are investing in public eye care initiatives aimed at reducing preventable blindness. These programs are increasing surgical volumes in government hospitals and regional ophthalmology centers, where reliable viscoelastic products are essential for maintaining intraocular space during procedures. Cohesive ophthalmic viscosurgical devices used in cataract surgery are expected to see the strongest demand. In addition, mobile surgical camps and public private partnerships are expanding access to treatment in rural areas, creating new procurement opportunities for manufacturers supplying cost efficient viscoelastic solutions.
Minimally invasive glaucoma surgery is emerging as an important growth segment for ophthalmic viscosurgical devices. These procedures require stable intraocular environments and controlled fluid dynamics, making cohesive and viscoadaptive viscoelastic solutions essential during device placement and tissue manipulation. As awareness of early glaucoma treatment increases, more patients are opting for minimally invasive procedures that offer faster recovery and reduced complications. Ophthalmology clinics and specialized glaucoma centers are therefore expanding their use of advanced viscoelastic materials designed for delicate intraocular procedures. This trend is expected to create growing demand for ophthalmic viscosurgical devices tailored specifically for glaucoma related surgical applications.
04

Challenge: Stringent Regulatory Approval Processes and Compliance Costs Slowing Product Innovation and Market Entry

Strict regulatory requirements for medical devices represent another major barrier to growth in the ophthalmic viscosurgical devices market. OVD manufacturers must meet rigorous standards for sterility, biocompatibility, and clinical performance before obtaining approvals from agencies such as the U.S. FDA or European regulators. These regulatory processes require extensive clinical trials, documentation, and compliance with evolving safety guidelines, increasing development timelines and operational costs. As a result, smaller companies often face difficulty entering the market, while established manufacturers must allocate substantial resources to regulatory compliance rather than rapid innovation. For instance, prolonged approval timelines can delay the launch of new viscoelastic formulations, slowing competitive product cycles and limiting the availability of advanced solutions in emerging markets. These regulatory burdens ultimately influence pricing structures, restrict supplier entry, and reshape competitive dynamics across the ophthalmic surgical devices ecosystem.

Supply Chain Landscape

1

Raw Material Suppliers

Dow CorningWacker Chemie AG
2

Component Manufacturers

Carl Zeiss MeditecJohnson & Johnson
3

Device Manufacturers

AlconBausch & Lomb
4

End Users

HospitalsSpecialty ClinicsAmbulatory Surgical Centers
Ophthalmic Viscosurgical Devices - Supply Chain

Use Cases of Ophthalmic Viscosurgical Devices in Cataract Surgery & Glaucoma Surgery

Cataract Surgery : Cataract surgery represents the largest application area for ophthalmic viscosurgical devices, as maintaining a stable anterior chamber and protecting intraocular structures is essential during lens removal and intraocular lens implantation. In this procedure, cohesive and dispersive ophthalmic viscosurgical devices are commonly used. Cohesive formulations help maintain space in the anterior chamber and facilitate precise capsulorhexis and lens implantation, while dispersive formulations provide strong coating protection for the corneal endothelium during phacoemulsification. Surgeons often select combination or viscoadaptive products to balance space maintenance and tissue protection. Their use improves surgical visibility, minimizes trauma to delicate ocular tissues, and supports smoother intraocular lens placement, contributing to better postoperative recovery and visual outcomes.
Glaucoma Surgery : Ophthalmic viscosurgical devices play an important role in glaucoma surgery by supporting controlled manipulation of intraocular tissues and stabilizing the anterior chamber during delicate procedures. In these surgeries, cohesive or viscoadaptive OVD are commonly preferred because they help maintain intraocular space while allowing surgeons to manage fluid dynamics effectively. During procedures such as trabeculectomy or minimally invasive glaucoma surgery, these devices protect the corneal endothelium and facilitate precise instrument navigation. They also assist in preventing chamber collapse and improving surgical visibility. By enabling safer intraocular access and reducing tissue stress, ophthalmic viscosurgical devices contribute to improved procedural control and better postoperative pressure management.
Corneal Transplantation : Corneal transplantation procedures rely on ophthalmic viscosurgical devices to protect sensitive ocular tissues and maintain surgical clarity during graft placement. In this application, dispersive ophthalmic viscosurgical devices are most commonly used because of their strong coating ability, which shields the corneal endothelium from mechanical trauma and surgical manipulation. These formulations help maintain the anterior chamber and provide a protective barrier while the surgeon removes damaged corneal tissue and positions the donor graft. Their ability to remain longer within the surgical field ensures continuous protection throughout the procedure. As corneal transplant techniques continue to evolve toward more precise lamellar approaches, the role of ophthalmic viscosurgical devices remains critical in supporting surgical safety and graft stability.

Recent Developments

Recent developments in the ophthalmic viscosurgical devices market reflect a strategic focus on advanced formulations and surgical compatibility. Leading manufacturers are introducing next-generation viscoadaptive and combination viscoelastic devices designed to support modern procedures such as micro-incision cataract surgery and laser-assisted ophthalmic surgery. These innovations improve intraocular stability and surgical efficiency, strengthening the role of ophthalmic surgical consumables in high-volume eye procedures. A key market trend is the shift toward biocompatible materials and dual-function cohesive-dispersive formulations, enabling surgeons to use a single viscoelastic solution for multiple intraoperative functions while enhancing workflow efficiency in cataract and glaucoma surgeries.

December 2024 : Johnson & Johnson Vision introduced a next-generation Ophthalmic Viscosurgical Device with advanced fluidic control, significantly improving surgical precision in cataract operations
October 2024 : Alcon Inc. launched a new Ophthalmic Viscosurgical Device with enhanced viscosity, providing better eye protection during surgery and reducing post-operative complications
August 2024 : Bausch & Lomb Incorporated expanded its Ophthalmic Viscosurgical Devices portfolio with a new high-performance device, ensuring superior patient outcomes in vitreoretinal procedures.

Impact of Industry Transitions on the Ophthalmic Viscosurgical Devices Market

As a core segment of the Medical Device industry, the Ophthalmic Viscosurgical Devices market develops in line with broader industry shifts. Over recent years, transitions such as Transition Toward Premium Viscoelastic Solutions in Advanced Ophthalmic Surgical Procedures and Shift From Hospital Based Procedures to High Volume Ambulatory Eye Surgery Centers have redefined priorities across the Medical Device sector, influencing how the Ophthalmic Viscosurgical Devices market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Transition Toward Premium Viscoelastic Solutions in Advanced Ophthalmic Surgical Procedures

The ophthalmic viscosurgical devices industry is transitioning from basic viscoelastic formulations to premium and combination products designed for advanced ophthalmic surgeries. As procedures such as micro incision cataract surgery and femtosecond laser assisted surgery become more common, surgeons increasingly prefer cohesive and viscoadaptive viscoelastic solutions that improve surgical control and efficiency. This shift is influencing procurement strategies in specialized eye hospitals and ambulatory surgical centers, where outcome driven product selection is becoming standard. The transition is also affecting the ophthalmic surgical equipment industry, as device manufacturers collaborate with viscoelastic suppliers to support integrated surgical ecosystems for cataract and glaucoma procedures.
02

Shift From Hospital Based Procedures to High Volume Ambulatory Eye Surgery Centers

Another important transition is the movement of ophthalmic surgeries from large hospitals to high volume ambulatory eye surgery centers. These specialized centers focus on efficiency, faster patient throughput, and cost optimized surgical workflows. As a result, demand for reliable ophthalmic viscosurgical devices that support quick and consistent surgical performance is increasing. This transition is influencing the broader ophthalmology services industry, where private eye care chains and specialized clinics are expanding their surgical capabilities. The shift also encourages manufacturers to develop packaging formats, product combinations, and supply partnerships that meet the operational needs of ambulatory surgical centers performing large numbers of cataract and glaucoma procedures.